MEDKO ONCOLOGY

What MEDKO ONCOLOGY does

MEDKO ONCOLOGY (legal name: Medko Sağlık Hizmetleri, Radyoterapi ve Tomoterapi Uygulama ve Eğitim Hizmeti) is a Turkish healthcare services provider founded in 1992 and headquartered in the Fatih district of Istanbul, with a secondary office in Ankara. The company delivers radiotherapy, Tomotherapy, Image-Guided Radiation Therapy (IGRT), and medical imaging services to cancer patients through on-site partnerships with university hospitals, training and research hospitals, and private hospital groups across at least nine Turkish provinces, including Istanbul, Izmir, Denizli, Sakarya, Sivas, Diyarbakir, Gaziantep, Adana, and Eskisehir. MEDKO operates as a wholly owned subsidiary of the MEDİTEL HEALTHCARE group and is privately held with no public listing, ticker, or disclosed external funding.

The company's core technical platform is Accuray's Tomotherapy system — a CT-based helical scanning radiotherapy device — combined with Accuray Precision integrated smart contouring and planning workstations used for medical physics planning. IGRT is layered on top of Tomotherapy to minimize tumor positioning errors prior to treatment delivery. Beyond clinical delivery, MEDKO operates a training business that has run since 1984 (predating formal incorporation) covering Radiology, Radiation Oncology, Cardiology, and medical physics, with course sessions reportedly drawing 20+ participants. The company has no disclosed patents, trademarks, certifications, AI/ML capabilities, or APIs.

MEDKO generates revenue through professional services fees tied to treatment delivery at partner hospitals and to training programs. Pricing is not publicly disclosed and is framed as determined through Turkish healthcare regulations and institutional/insurance frameworks. The company reports an average patient satisfaction rate of 92.73% across surveyed partner sites, with the highest score (95.27%) at Izmir Katip Celebi University Training and Research Hospital. Go-to-market is exclusively B2B institutional: MEDKO does not sell directly to consumers, runs no app, and earns revenue per treatment session and per training cohort delivered on partner premises.

Name

MEDKO ONCOLOGY

Legal name

Medko Sağlık Hizmetleri, Radyoterapi ve Tomoterapi Uygulama ve Eğitim Hizmeti

Website

https://medko.com.tr

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

MEDKO ONCOLOGY is a Turkish healthcare services provider, founded in 1992, operating Tomotherapy and radiotherapy equipment across multiple Turkish provinces under institutional partnerships with university hospitals and private hospital groups.

Ownership category

akta.pro rank

Product category

Radiation Oncology Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

Keywords

• Radiotherapy services
• Tomotherapy treatment
• Radiation oncology
• Medical imaging services
• Healthcare training

Headquarters

HQ city

Istanbul

HQ country

Türkiye

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Medical Treatment Services: MEDKO provides radiotherapy and tomotherapy treatment services to patients through partnerships with hospitals and medical centers. Services are delivered in daily sessions over days or weeks as determined by radiation oncologists.
2. Healthcare Training Services: Training services provided to healthcare professionals in radiology, radiation oncology, and cardiology fields since 1984. Includes medical physics courses and continuing education programs.
3. Medical Imaging Services: Medical imaging services as part of cancer diagnosis and treatment, operating in partnership with various hospitals and university medical centers across Turkey.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

MEDKO provides radiotherapy and tomotherapy cancer treatment services at partner hospitals and university medical centers across Turkey. Using Accuray's TomoTherapy equipment with integrated IGRT, the company administers daily radiation therapy sessions to cancer patients through on-site operations. The company also delivers medical imaging services for cancer diagnosis and continuing education programs in radiology, radiation oncology, and cardiology since 1984.

Differentiator

Problem solved

Functional benefit

Products and services

• Radiotherapy A treatment service that eliminates tumor cells by applying ionizing radiation generated by radiation therapy devices to the diseased area. Treatments are administered in daily sessions over days or weeks to destroy cancer cells while minimizing damage to surrounding healthy tissues. Delivered at partner hospitals across Turkey for cancer patients referred by radiation oncologists.
• Tomotherapy A type of external radiotherapy delivered via Accuray's TomoTherapy system that operates on the principle of Computed Tomography (CT), delivering treatment by helically scanning tumor tissue. The IGRT image obtained prior to treatment ensures precise and safer treatment by minimizing errors in tumor positioning. Provided on-site at partner hospitals to cancer patients requiring CT-image-guided precision radiation therapy.
• Medical Imaging Services Medical imaging services used as part of cancer diagnosis and treatment, operating in partnership with hospitals and university medical centers across Turkey. Supports the diagnostic pathway for cancer patients prior to or during radiotherapy/tomotherapy treatment.
• Healthcare Training (Education) Medical education and training programs delivered since 1984 in the fields of Radiology, Radiation Oncology, and Cardiology. Includes Medical Physics courses featuring Accuray's Precision integrated smart contouring and planning workstations, with over 20 participants per session. Targeted at medical physicists, radiation oncologists, radiologists, and other healthcare professionals seeking continuing education and specialized training on advanced radiotherapy equipment.

Quantifiable outcome

• Patient satisfaction rate of 92.73% average across all service locations
• +1 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and flagship.

• AccuraycoreTechnology or IntegrationMEDKO uses Accuray's Precision integrated smart contouring and planning workstations for medical physics courses and treatment planning. Accuray manufactures the TomoTherapy equipment that MEDKO operates. This is a core technology partnership essential to MEDKO's service delivery.
• MEDITEL HEALTHCAREflagshipStrategic or Co-development PartnerMEDKO is a subsidiary of MEDITEL HEALTHCARE group. The parent company organizes breast cancer awareness campaigns (Pinktober) and training programs. MEDITEL Healthcare coordinates the broader oncology network including Medko Oncology Network locations.
• Medical Physics Association (Medikal Fizik Derneği)coreStrategic or Co-development PartnerPartnership with Medical Physics Association for organizing medical physics training courses. The association board is involved in curriculum development and certification for training programs.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• ICON plc: Globally diversified contract research and cancer care services organization. Comparably operates oncology services at scale across multiple sites and geographies, providing a broader-services benchmark for MEDKO's radiation oncology focused model.
• Elekta: Major radiotherapy and radiosurgery equipment manufacturer (Elekta Unity, Versa HD, Gamma Knife) that competes for the same capital equipment purchases across MEDKO's hospital partner network and whose installed-base drives alternative service contracts.
• Varian (Siemens Healthineers): Leading radiation oncology equipment manufacturer (now part of Siemens Healthineers) offering linacs, treatment planning, and oncology software to the same Turkish university hospitals that MEDKO serves — competes for technology budgets that fund radiotherapy operations.
• McKesson / US Oncology Network: US oncology care platform with extensive community-based radiation oncology practices. Comparable specialist-services model at much greater scale, providing reference benchmarks for site productivity and partnership economics.

Regional players

• Anadolu Medical Center: Johns Hopkins-affiliated Turkish cancer center providing advanced radiation oncology services in Istanbul and Kocaeli. Competes with MEDKO's partner-hospital sites in the Marmara region for both local patients and regional referrals.
• Medical Park Hospitals Group: Large Turkish hospital group with oncology and radiation therapy departments. A current MEDKO service-location partner (Bahçelievler) and a regional competitor in private-hospital cancer care delivery.
• Acibadem Healthcare Group: Turkey's largest private hospital chain with oncology and radiotherapy offerings across multiple cities. Notably also a current MEDKO customer (Atakent, Adana, Eskişehir), but its in-house oncology capabilities make it a comparable peer that could choose to insource.
• Memorial Healthcare Group (Turkey): Major Turkish private hospital group with dedicated oncology centers including radiation therapy. Operates in the same Turkish geography as MEDKO and targets the same cancer-patient segment, making it a direct regional competitor for advanced radiotherapy cases.

Others

• Accuray: Manufacturer of TomoTherapy equipment and the Precision planning workstations that MEDKO uses. Although a core technology partner and equipment supplier rather than a service competitor, Accuray sets the innovation cadence and pricing terms that directly shape MEDKO's operating economics.

Direct peers

• GenesisCare: Global operator of cancer treatment centers providing radiotherapy, including advanced modalities, via hospital partnerships and standalone clinics. Closely mirrors MEDKO's specialist radiation oncology service model across multiple sites, making it the most directly comparable peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/medko-makina-i%CC%87thalat-i%CC%87hracat-a-%C5%9F

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDKO ONCOLOGY